Verseon Competitors and Similar CompaniesClear all

Curi Bio's competitors and similar companies include Walvax Biotechnology and SIGA Technologies.
Curi Bio
Curi Bio
Curi Bio is a biotechnology company developing human-relevant platforms and advanced tissue models for drug discovery and development.
Walvax Biotechnology
Walvax Biotechnology
Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs.
SIGA Technologies
SIGA Technologies
SIGA Technologies is a biopharmaceutical company that develops treatments for infectious diseases.
Founding Date
Founding Date
2015
Founding Date
2001
Founding Date
1995
Type
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Seattle, US HQ
Locations
Kunming, CN HQ
Locations
New York, US HQ
Corvallis, US
Employees
Employees
44
Employees
2,388
Employees
4515% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
3.3 b
Valuation ($)
507.4 m

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
¥2.4b (FY, 2025)
Revenue (est.)
$94.6m (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
¥615.2m (FY, 2025)
Cost of goods
$29.7m (FY, 2025)
Gross profit
Gross profit
N/A
Gross profit
¥1.8b (FY, 2025)
Gross profit
$64.9m (FY, 2025)
Net income
Net income
N/A
Net income
¥125.2m (FY, 2025)
Net income
$23.3m (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 6m
Total funding raised
$ 72.8m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Walvax Biotechnology
HQ
Kunming, CN
Employees
2,388

Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs.

View company
SIGA Technologies
HQ
New York, US
Employees
45↑ 15% increase

SIGA Technologies is a biopharmaceutical company that develops treatments for infectious diseases.

View company